Carregant...
Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
BACKGROUND: Secondary prevention of atrial fibrillation (AF) could be carried out by means of antiarrhythmic drugs; however this strategy has not received any endorsement because these drugs are burdened by a high risk of proarrhythmic events (flecainide, sotalol) or extracardiac effects (amiodarone...
Guardat en:
| Publicat a: | Cardiol Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elmer Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681845/ https://ncbi.nlm.nih.gov/pubmed/31413779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr909 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|